Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy

Published: 14-02-2019| Version 1 | DOI: 10.17632/x5xyn9bz38.1
Contributor:
Huijuan Wang

Description

Supplement 2. Major clinicopathological characteristics of 99 patients with uncommon EGFR mutation.

Files